AF
VIVO

Arrow Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Arrow Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$2K – 392
2015
Q1 		$2K Hold
100
– – ﹤0.01% 370
2014
Q4 		$2K Hold
100
– – ﹤0.01% 337
2014
Q3 		$2K Buy
+100
New +$1.97K ﹤0.01% 401

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Arrow Financial's VIVO Position: Q2 2015 in Review

Arrow Financial sold out of Meridian Bioscience Inc (VIVO) in Q2 2015, closing a stake of 100 shares — an estimated $2K sold.

Arrow Financial first reported a position in VIVO in Q3 2014 and held it in 3 quarters. The position peaked at $2K in Q1 2015. 167 funds tracked by Wall St. Rank hold VIVO as of Q2 2015.

  • Arrow Financial reported no remaining Meridian Bioscience Inc position as of Q2 2015 after selling out during the quarter.
  • Arrow Financial sold 100 Meridian Bioscience Inc shares in Q2 2015, an estimated $2K.
  • Arrow Financial first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 3 quarters.
  • Arrow Financial's Meridian Bioscience Inc position peaked at $2K in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2015.

Based on Arrow Financial's 13F filing for Q2 2015, filed 28 Jul 2015.